Your browser doesn't support javascript.
loading
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens.
Dai, Ming Shen; Feng, Yin Hsun; Chen, Shang Wen; Masuda, Norikazu; Yau, Thomas; Chen, Shou Tung; Lu, Yen Shen; Yap, Yoon Sim; Ang, Peter C S; Chu, Sung Chao; Kwong, Ava; Lee, Keun Seok; Ow, Samuel; Kim, Sung Bae; Lin, Johnson; Chung, Hyun Cheol; Ngan, Roger; Kok, Victor C; Rau, Kun Ming; Sangai, Takafumi; Ng, Ting Ying; Tseng, Ling Ming; Bryce, Richard; Bebchuk, Judith; Chen, Mei Chieh; Hou, Ming Feng.
Afiliación
  • Dai MS; Department of Hematology-Oncology, Tri-Service General Hospital, Taipei, Taiwan.
  • Feng YH; Department of Hematology-Oncology, Chi Mei Medical Center-Yongkang Branch, Tainan, Taiwan.
  • Chen SW; Department of Hematology-Oncology, Chi Mei Medical Center-LiouYing Branch, Tainan, Taiwan.
  • Masuda N; Department of Surgery and Breast Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan.
  • Yau T; Department of Medicine, The University of Hong Kong, Hong Kong, Hong Kong.
  • Chen ST; Department of Surgery, Changhua Christian Hospital, Changhua, Taiwan.
  • Lu YS; Division of Medical Oncology, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Yap YS; Department of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Ang PCS; Department of Medical Oncology, OncoCare Cancer Centre, Singapore, Singapore.
  • Chu SC; Department of Hematology-Oncology, Hualien Tzu Chi Hospital, Hualien, Taiwan.
  • Kwong A; Department of Surgery, The University of Hong Kong Li Ka Shing Faculty of Medicine, Hong Kong, Hong Kong.
  • Lee KS; Center for Breast Cancer, National Cancer Center, Goyang-si, South Korea.
  • Ow S; Department of Haematology and Oncology, National University Cancer Institute, Singapore, Singapore.
  • Kim SB; Department of Oncology, Asan Medical Center, Seoul, South Korea.
  • Lin J; Department of Hematology-Oncology, Mackay Memorial Hospital, Taipei, Taiwan.
  • Chung HC; Department of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
  • Ngan R; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, Hong Kong.
  • Kok VC; Division of Medical Oncology, Kuang Tien General Hospital Cancer Center, Taichung, Taiwan.
  • Rau KM; Department of Hematology-Oncology, E-Da Cancer Hospital, Kaohsiung, Taiwan.
  • Sangai T; Department of Breast and Thyroid Surgery, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
  • Ng TY; Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong, Hong Kong.
  • Tseng LM; Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Bryce R; Puma Biotechnology Inc., Los Angeles, USA.
  • Bebchuk J; Department of Biostatistics, Puma Biotechnology Inc., Los Angeles, USA.
  • Chen MC; Clinical Development and Medical Affairs, CANbridge Pharmaceuticals Inc., Taipei, Taiwan.
  • Hou MF; Division of Breast Oncology and Surgery, Kaohsiung Medical University Chung-Ho Memorial Hospital, No.100, Tzyou 1st Road, Kaohsiung, 807, Taiwan. mifeho@kmu.edu.tw.
Breast Cancer Res Treat ; 189(3): 665-676, 2021 Oct.
Article en En | MEDLINE | ID: mdl-34553296
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2021 Tipo del documento: Article País de afiliación: Taiwán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2021 Tipo del documento: Article País de afiliación: Taiwán